Core Viewpoint - Neurodegenerative diseases, such as Alzheimer's and Parkinson's, affect 1 in every 12 people globally and currently lack curative methods. The core mechanism involves the loss of protein homeostasis and accumulation of protein aggregates in neurons as age increases [3]. Group 1: Research Findings - A study published by Stanford University in Nature reveals that the half-life of neuronal proteins in older brains is on average doubled compared to younger brains, indicating a significant decline in protein homeostasis with age [3]. - The research found that 54% of proteins in aging microglia show reduced degradation and/or accumulation with age, particularly synaptic proteins, which may lead to synaptic loss and cognitive decline [3][6]. Group 2: Protein Homeostasis and Aging - The brain's protein homeostasis, which maintains a balance between protein synthesis and degradation, deteriorates with age, leading to the accumulation of "protein waste" in neurons [6]. - The study highlights that the average half-life of neuronal proteins increases by approximately 100% from young to old age, meaning that older brains clear proteins at about half the rate of younger brains [10]. Group 3: Implications of Protein Accumulation - The research identified 1,726 neuronal proteins in the aging brain, with nearly half showing slowed degradation and/or forming aggregates, including risk gene products associated with neurodegenerative diseases [12]. - Notably, 54% of aggregated proteins exhibit decreased degradation rates with age, indicating that degradation defects directly contribute to protein accumulation, particularly affecting synaptic proteins [12]. Group 4: Role of Microglia - Microglia, the brain's immune cells, are responsible for clearing cellular debris and protein waste. The study found that aging neurons transfer proteins to microglia, which become overwhelmed as the amount of protein to process increases significantly in older mice [14]. - In aged microglia, the quantity of neuronal proteins is over ten times that found in younger mice, with more than half showing degradation defects and/or aggregation tendencies [14]. Group 5: Future Applications - The study not only uncovers new mechanisms of brain aging but also provides a powerful tool for studying protein dynamics. The BONCAT technology can be used to screen for drugs that promote protein degradation, offering new targets for treating age-related brain diseases [18]. - Future interventions may focus on enhancing the degradation capabilities of neurons or improving the clearance abilities of microglia to alleviate protein aggregation [18].

Core Viewpoint - The study highlights the role of the E3 ubiquitin ligase KLHL6 as a dual negative regulator of T cell exhaustion and mitochondrial dysfunction during chronic antigen stimulation, suggesting its potential as a clinical target to enhance cancer immunotherapy effectiveness [5][7][9]. Group 1: T Cell Dysfunction and Mechanisms - T cell dysfunction, including exhaustion and mitochondrial impairment, is a major barrier in cancer immunotherapy [7]. - The research combines computational analysis with in vivo CRISPR screening to identify KLHL6 as a key factor in regulating T cell exhaustion and mitochondrial health [5][7]. - KLHL6 expression promotes the polyubiquitination and subsequent proteasomal degradation of the exhaustion core regulator TOX, inhibiting the transition from precursor exhausted T cells (Tpex) to terminal exhausted T cells (Tex-term) [7][9]. Group 2: Therapeutic Implications - Enhancing KLHL6 expression in T cells significantly improves anti-tumor and anti-viral efficacy, indicating its critical role in T cell fate and function [5][8]. - The study suggests a new therapeutic approach to restore or enhance KLHL6 expression to reverse T cell exhaustion during chronic TCR stimulation [8][9]. - The findings underscore the potential of targeting protein homeostasis and ubiquitination modifications to improve immunotherapy outcomes [9][10].

Core Viewpoint - Aging significantly increases the risk of cancer and profoundly affects the immune system, leading to impaired immune responses to chronic and acute infections, as well as a higher susceptibility to autoimmune diseases [2]. Group 1: Research Findings - A study published by researchers at the Moffitt Cancer Center indicates that lymphoma accelerates T cell and tissue aging [3][4]. - The research shows that lymphoma induces transcriptional, epigenetic, and phenotypic changes in young T cells, which are also reflected in older T cells [8]. - Aging T cells exhibit strong resistance to changes induced by lymphoma, while lymphoma itself accelerates aging in young T cells and tissues [9]. Group 2: Immune System Changes - Aging leads to numerous changes in the immune system, including an imbalance of inflammatory cytokines and chemokines, a shift in hematopoietic stem cells towards monocyte generation, and a reduction in lymphocyte populations [6]. - Tumors escape immune surveillance by creating various pressures, such as an acidic environment that damages CD8+ T cells while promoting the expansion of regulatory T cells (Tregs) [7]. - The study highlights that lymphoma drives age-related inflammation and alters protein and iron homeostasis in T cells [9].

Core Viewpoint - The article discusses a groundbreaking study that constructs a comprehensive human proteome aging map across a 50-year lifespan, revealing critical insights into the molecular mechanisms of aging and potential intervention targets [3][4][19]. Group 1: Research Findings - The study integrates ultra-sensitive mass spectrometry and machine learning to create a dynamic landscape of protein aging across seven physiological systems and 13 key tissues [4]. - It identifies protein information disruption as a core feature of organ aging, highlighting the role of mRNA-protein decoupling and pathological amyloid deposition in the systemic collapse of proteostasis networks [7]. - The vascular system is established as a "pioneer organ" in the aging process, significantly deviating from homeostatic trajectories early in life [7]. Group 2: Molecular Characterization of Aging - The research confirms that aging is accompanied by systemic proteostasis imbalance, characterized by a breakdown of the central dogma information flow, leading to impaired conversion of genetic information into functional proteins [9]. - Key findings include widespread accumulation of pathological proteins, forming an inflammatory aging network, which serves as a molecular basis for inflammaging [9][10]. Group 3: Aging Milestones and Mechanisms - The study identifies around 30 years of age as a critical inflection point for aging trajectories, with adrenal tissues showing early aging characteristics [12]. - A significant biological transition occurs between 45-55 years, where most organ proteomes experience a "molecular cascade storm," marking a key window for systemic aging acceleration [12][21]. Group 4: Vascular Aging Mechanisms - The research validates the "vascular aging hub" hypothesis, demonstrating that specific senescence-associated secretory factors, such as GAS6, drive endothelial and smooth muscle cell aging [15][16]. - Evidence supports the theory of "aging diffusion," where local aging tissues influence distant organs through specific secretory factors [16]. Group 5: Implications for Aging Research and Interventions - The study proposes a new framework for systemic aging research, moving beyond single-tissue models to a multi-organ interaction network [19]. - It introduces a novel tool for precise aging assessment through the development of organ-specific "proteome aging clocks," enabling non-invasive evaluation of biological age [20]. - Key intervention targets are identified, including factors mediating inter-organ signaling and common biomarkers, with the 45-55 age range highlighted as a critical intervention window [21]. - The findings pave the way for proactive aging disease prevention strategies, shifting from reactive treatment to early intervention based on molecular aging clocks [23]. Group 6: Methodological Innovations - The research successfully combines ultra-sensitive mass spectrometry, AI modeling, and multi-scale omics analysis to create a comprehensive framework for studying aging [24]. - This methodological advancement enhances the understanding of human aging and accelerates the translation of life sciences technologies into clinical applications [24].